Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with non-small cell lung cancer at clinical stage I or II
- People whose cancer is able to be surgically removed, with a complete surgical removal planned
- People being treated through companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, or the Vanderbilt-Ingram Cancer Center Affiliate Network
- Tumor tissue samples must be available at the time of surgery
Who may not be able to join:
- People who have received chemotherapy before surgery
- People who have received radiation therapy before surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eric Grogan, MD, Vanderbilt Medical Center
Phone: 800-811-8480
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Protein and RNA expression fingerprints from collected samples
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.